Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation

Martino M., Lanza F., DEMİRER T., Moscato T., Secondino S., Pedrazzoli P.

EXPERT OPINION ON BIOLOGICAL THERAPY, cilt.15, sa.2, ss.195-211, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 15 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1517/14712598.2015.971749
  • Dergi Adı: EXPERT OPINION ON BIOLOGICAL THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.195-211
  • Anahtar Kelimeler: allogeneic hematopoietic stem cell transplant, autologous hematopoietic stem cell transplant, erythropoiesis-stimulating agents, erythropoietin, RECOMBINANT-HUMAN-ERYTHROPOIETIN, BONE-MARROW-TRANSPLANTATION, QUALITY-OF-LIFE, CLINICAL-PRACTICE GUIDELINE, CHEMOTHERAPY-INDUCED ANEMIA, EPOETIN-ALPHA, CANCER-PATIENTS, PERIPHERAL-BLOOD, DARBEPOETIN-ALPHA, INTRAVENOUS IRON
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction: Erythropoiesis-stimulating agents (ESAs) are used in treating cancer- and chemotherapy-induced anemia with the aim of accelerating the recovery of red blood cells (RBCs), reduce the risks associated with RBC transfusions and improve quality of life.